Interaction between type 2 diabetes and past COVID-19 on active tuberculosis
DM interacts with past COVID-19 synergistically to magnify the risk of TB. Latent TB screening and prophylactic treatment, if positive, is recommended in past COVID-19 persons with DM. Future studies are warranted with a longitudinal design and larger sample size to confirm our findings.
Authors
- Génesis P. Aguillón-Durán
- Raúl Loera-Salazar
- Esperanza M. García-Oropesa (ORCID: https://orcid.org/0000-0002-4803-1143)
- Mateo Joya-Ayala
- Jordi Bertran Torrelles (ORCID: https://orcid.org/0000-0001-7702-5941)
- America M. Cruz-Gonzalez
- Miguel Garza
- Javier E. Rodríguez-Herrera
- José Ángel Gómez de Caso
- Blanca I. Restrepo (ORCID: https://orcid.org/0000-0002-3743-9098)
- Ericka Prieto-Martínez
- Doris Ayala
- Miryoung Lee (ORCID: https://orcid.org/0000-0003-4088-304X)
- Liz E. Calles-Cabanillas
- John Thomas (ORCID: https://orcid.org/0000-0003-0782-1517)
Institutions
- Texas Biomedical Research Institute (US)
- The University of Texas Rio Grande Valley (US)
- Autonomous University of Tamaulipas (MX)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1186/s12879-024-10244-z
- Citations
- 1
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Secretaría de Salud
- National Institutes of Health
- National Institute on Aging
- National Institute of General Medical Sciences
- National Institute of Allergy and Infectious Diseases